Vanderbilt Kennedy Center

Elise McMillan, JD
June 21, 2023

Elise McMillan to retire as Vanderbilt Kennedy Center UCEDD director

Elise McMillan, JD, has announced she will retire from the Vanderbilt Kennedy Center this month.

By VUMC News and Communications
January 26, 2023

Hine to lead DDM, TRIAD outreach and training efforts

Jeffrey Hine, PhD, has been named director of Primary Care Outreach and Training for the Vanderbilt Kennedy Center (VKC), the VKC Treatment and Research Institute for Autism Spectrum Disorders and the Division of Developmental Medicine.

By VUMC News and Communications
January 17, 2023

Vanderbilt Kennedy Center seeks adults 18-30 to study effects of noise on brain activity

The Vanderbilt Kennedy Center is seeking adult participants (ages 18 to 30) for a research study investigating the effects of different noise conditions on brain activity during the Attentional Network Task.

By VUMC News and Communications
November 10, 2022

Kennedy Center seeks participants for disabilities research learning sessions

In January, a series of online learning sessions hosted by Vanderbilt Kennedy Center will bring together stakeholders who wish to see research advance toward understanding and solving the health problems that tend to affect adults with IDD.

By Paul Govern
September 8, 2022

Juárez named director of behavior analysis

Pablo Juárez, MEd, BCBA, LBA, has been named director of behavior analysis within the Vanderbilt Kennedy Center and the Division of Developmental Medicine at Vanderbilt University Medical Center.

By Courtney Taylor
April 28, 2022

Rajaraman named TRIAD director of behavioral analysis

Adithyan Rajaraman, PhD, BCBA-D, LBA, has been named director of the Vanderbilt Kennedy Center Treatment & Research Institute for Autism Spectrum Disorders.

By Courtney Taylor
December 28, 2021

Vanderbilt Kennedy Center produces videos to build vaccine confidence in disability community

By VUMC News and Communications
December 6, 2021

Potential Rett syndrome drug shows promising results in phase 3 trial

A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety.
By Craig Boerner
December 2, 2021

VKC data shows increase in autism spectrum disorder prevalence, provides new data on 4-year-olds

Vanderbilt Kennedy Center (VKC) researchers are seeing an increase in the number of children in Tennessee with autism spectrum disorder (ASD).
By Emily Stembridge
October 28, 2021

SENSE Theatre production of “The Adult School” brings together diverse cast

The goal of the SENSE Theatre program is to improve the social and emotional functioning of individuals with autism spectrum disorder through using behavioral and theater techniques.
By Erin O. Smith
September 30, 2021

Project seeks to treat Alzheimer’s in people with Down syndrome

A joint project between the Vanderbilt Kennedy Center and the Vanderbilt Center for Cognitive Medicine will help deliver Alzheimer’s disease therapies and treatments to people with Down syndrome (DS). 
By Emily Stembridge
September 30, 2021

Project seeks to make zoos more autism-friendly

Vanderbilt is collaborating with Oregon State University and the Association of Zoos and Aquariums to support the Modeling Zoos and Aquariums as Inclusive Communities of Science (MoZAICS) project.
By Emily Stembridge
July 30, 2021

Kennedy Center efforts enhance inclusivity in clinical trials

Following the Vanderbilt Kennedy Center’s (VKC) renewal as a national Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center in 2020, the center underwent a shuffling of their four scientific cores that support basic and applied research on intellectual and developmental disabilities (IDD).
By Emily Stembridge